Today’s guest post comes from Gerard Rivera, CEO and Co-Founder of RIS Rx. Gerard explores how pharma companies lose billions each year through copay program inefficiencies, accumulators, maximizers, and other forms of systemic leakage. He introduces RIS Rx, a healthcare technology company whose platform helps manufacturers mitigate gross-to-net (GTN) revenue leakage while supporting patient access and outcomes. Click here to request a free savings snapshot from the RIS Rx platform for your...
